Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1990; Volume 255,Issue 2
  • You have access
    L-tyrosine potentiates the anorexia induced by mixed-acting sympathomimetic drugs in hyperphagic rats.
    K M Hull and T J Maher
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 403-409;
  • You have access
    Suppressive effects of morphine pellet implants on in vivo parameters of immune function.
    H U Bryant and R E Roudebush
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 410-414;
  • You have access
    CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
    R P Garay, J P Labaune, D Mesangeau, C Nazaret, T Imbert and G Moinet
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 415-422;
  • You have access
    Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery.
    S P Han, L Naes and T C Westfall
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 423-428;
  • You have access
    Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
    C Ripoll, W J Lederer and C G Nichols
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 429-435;
  • You have access
    Effect of DQ-2556, a new cephalosporin, on organic ion transport in renal plasma membrane vesicles from the dog, rabbit and rat.
    P P Sokol
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 436-441;
  • You have access
    In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6.
    F Zavala, V Taupin and B Descamps-Latscha
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 442-450;
  • You have access
    Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
    A I Faden, R Shirane, L H Chang, T L James, M Lemke and P R Weinstein
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 451-458;
  • You have access
    Mechanisms of potassium channel block in rat alveolar epithelial cells.
    E R Jacobs and T E DeCoursey
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 459-472;
  • You have access
    Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney.
    M Y Farhat, P W Ramwell and G Thomas
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 473-477;
  • You have access
    Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    C J Schmidt, G M Abbate, C K Black and V L Taylor
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 478-483;
  • You have access
    Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat.
    T Shimizu, T Kawabata and M Nakamura
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 484-490;
  • You have access
    Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
    P G Cox, W M Moons, F G Russel and C A van Ginneken
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 491-496;
  • You have access
    Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
    J G Drewett, R J Ziegler and G J Trachte
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 497-503;
  • You have access
    A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig.
    Y Kumagai, T Todaka and S Toki
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 504-510;
  • You have access
    Pharmacology of pravadoline: a new analgesic agent.
    D R Haubrich, S J Ward, E Baizman, M R Bell, J Bradford, R Ferrari, M Miller, M Perrone, A K Pierson and J K Saelens
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 511-522;
  • You have access
    Naloxone potentiation of cardiovascular responses to sympathomimetic amines in the rat.
    M Feria, C Alvarez, J Domínguez, A Sánchez and J Boada
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 523-528;
  • You have access
    Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
    E Freneaux, B Fromenty, A Berson, G Labbe, C Degott, P Letteron, D Larrey and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 529-535;
  • You have access
    Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: comparison with kappa, mu and delta opioid receptors.
    A L Giordano, B Nock and T J Cicero
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 536-540;
  • You have access
    Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    W Löscher, D Hönack, R Scherkl, A Hashem and H H Frey
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 541-548;
  • You have access
    A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    H E Shannon and S C Peters
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 549-553;
  • You have access
    On the metallothionein, glutathione and cysteine relationship in rat liver.
    J Hidalgo, J S Garvey and A Armario
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 554-564;
  • You have access
    Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents.
    R C Falcone and D Aharony
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 565-571;
  • You have access
    Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
    D J Fretland, D Widomski, B S Tsai, J M Zemaitis, S Levin, S W Djuric, R L Shone and T S Gaginella
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 572-576;
  • You have access
    Effect of aging on hepatic biotransformation in female Fischer 344 rats: changes in sulfotransferase activities are consistent with known gender-related changes in pituitary growth hormone secretion in aging animals.
    R E Galinsky, D H Johnson, R E Kane and M R Franklin
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 577-583;
  • You have access
    Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    P C Wong, S D Hart, A M Zaspel, A T Chiu, R J Ardecky, R D Smith and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 584-592;
  • You have access
    SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    P Polster, B Christophe, M Van Damme, A Houlliche and P Chatelain
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 593-599;
  • You have access
    SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    P Nokin, M Clinet, P Beaufort, L Meysmans, R Laruel and P Chatelain
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 600-607;
  • You have access
    Effects of TRH-analog treatment on tissue cations, phospholipids and energy metabolism after spinal cord injury.
    A I Faden, S W Yum, M Lemke and R Vink
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 608-614;
  • You have access
    Cimetidine transport in isolated brush border membrane vesicles from bovine choroid plexus.
    M T Whittico, Y A Gang and K M Giacomini
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 615-623;
  • You have access
    Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
    B F Thomas, D R Compton and B R Martin
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 624-630;
  • You have access
    Dipyridamole inhibition of HCO3(-)-Cl- exchange in human erythrocytes.
    T A Heming, C G Vanoye and A Bidani
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 631-635;
  • You have access
    Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    J A Qi, W D Bowen, H I Mosberg, R B Rothman and F Porreca
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 636-641;
  • You have access
    Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
    J Turgeon, H N Pavlou, W Wong, C Funck-Brentano and D M Roden
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 642-649;
  • You have access
    Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta.
    S A Keitz, R Osman, W P Clarke, J Goldfarb and S Maayani
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 650-656;
  • You have access
    A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties.
    M Maitre, V Hechler, P Vayer, S Gobaille, C D Cash, M Schmitt and J J Bourguignon
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 657-663;
  • You have access
    Evidence that peptidoleukotriene is a prerequisite for antigen-dependent thromboxane synthesis in IgG1-passively sensitized guinea pig lungs.
    J B Cheng, J S Pillar, M J Conklyn, R Breslow, J T Shirley and H J Showell
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 664-671;
  • You have access
    Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
    N A Boughattas, F Lévi, C Fournier, B Hecquet, G Lemaigre, A Roulon, G Mathé and A Reinberg
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 672-679;
  • You have access
    Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
    Y Nasa, K Ichihara and Y Abiko
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 680-689;
  • You have access
    The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
    G K Lloyd, G Danielou and F Thuret
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 690-696;
  • You have access
    Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
    T R Jones, L Charette, M L Garcia and G J Kaczorowski
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 697-706;
  • You have access
    Influence of chronic alcohol administration on representative indices of puberty and sexual maturation in male rats and the development of their progeny.
    T J Cicero, M L Adams, L O'Connor, B Nock, E R Meyer and D Wozniak
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 707-715;
  • You have access
    Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
    T Okaniwa, H Echizen, T Ishizaki, M Kasao and T Iizuka
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 716-723;
  • You have access
    Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
    H Tanaka and T Tokiwa
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 724-729;
  • You have access
    Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
    K C Kirby, M L Stitzer and S J Heishman
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 730-737;
  • You have access
    Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
    C D Jeck and M R Rosen
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 738-743;
  • You have access
    Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    W R Martin, J W Sloan and E Wala
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 744-755;
  • You have access
    Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
    J E Bleasdale, N R Thakur, R S Gremban, G L Bundy, F A Fitzpatrick, R J Smith and S Bunting
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 756-768;
  • You have access
    Naloxone benzoylhydrazone (NalBzoH) analgesia.
    D Paul, J A Levison, D H Howard, C G Pick, E F Hahn and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 769-774;
  • You have access
    Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    K M Merchant, L G Bush, J W Gibb and G R Hanson
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 775-780;
  • You have access
    Augmentation of release of gastric somatostatin-like immunoreactivity by adenosine, adenosine triphosphate and their analogs.
    Y N Kwok, C McIntosh and J Brown
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 781-788;
  • You have access
    Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
    T Nabeshima, K Tohyama, K Ichihara and T Kameyama
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 789-794;
  • You have access
    Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
    C G Parsons and A Herz
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 795-802;
  • You have access
    Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
    L Ahtee, L M Attila and K R Carlson
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 803-808;
  • You have access
    Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.
    P C Chang, K Szemeredi, E Grossman, I J Kopin and D S Goldstein
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 809-817;
  • You have access
    Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    K Masuzawa, M Asano, T Matsuda, Y Imaizumi and M Watanabe
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 818-825;
  • You have access
    Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.
    R Kawai, Y Sawada, M Channing, B Dunn, A H Newman, K C Rice and R G Blasberg
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 826-835;
  • You have access
    Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    J F Giudicelli, C D la Rochelle and A Berdeaux
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 836-842;
  • You have access
    Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    N M Appel, W M Mitchell, R K Garlick, R A Glennon, M Teitler and E B De Souza
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 843-857;
  • You have access
    Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
    D Beauchamp, G Laurent, P Maldague, S Abid, B K Kishore and P M Tulkens
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 858-866;
  • You have access
    Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    B K Kishore, Z Kállay, P Lambricht, G Laurent and P M Tulkens
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 867-874;
  • You have access
    Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    B K Kishore, P Lambricht, G Laurent, P Maldague, R Wagner and P M Tulkens
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 875-885;
  • You have access
    On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.
    W P Schiemann, J M Walther and I L Buxton
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 886-892;
  • You have access
    Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.
    W M Pardridge, D Triguero, J Buciak and J Yang
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 893-899;
  • You have access
    Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
    C Alzheimer and G ten Bruggencate
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 900-905;
  • You have access
    Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative).
    H Hara and K Kogure
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 906-913;
  • You have access
    Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats.
    B A Sabel, P Dominiak, W Häuser, M J During and A Freese
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 914-922;
  • You have access
    Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
    J Szolcsanyi, A Szallasi, Z Szallasi, F Joo and P M Blumberg
    Journal of Pharmacology and Experimental Therapeutics November 1990, 255 (2) 923-928;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 255, Issue 2
1 Nov 1990
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics